Novo Nordisk appoints Ludovic Helfgott executive vice president Biopharm
(WorldNews Denmark)

Novo Nordisk appoints Ludovic Helfgott executive vice president Biopharm Bagsværd, Denmark, 15 October 2018 - Novo Nordisk A/S today announced the appointment of Ludovic Helfgott as executive vice president of Biopharm, effective 3 April 2019. Based in Zürich, Switzerland, Helfgott will lead the development of Novo Nordisk`s Biopharm business, which comprises the company`s haemophilia and human growth hormone franchises. He will be a member of Novo Nordisk`s Executive Management team and report to CEO Lars Fruergaard Jørgensen. Ludovic Helfgott joins Novo Nordisk from AstraZeneca where he most recently was global vice president in charge of the company`s Cardiovascular, Metabolism and...